Lorati Introduces Nano-Emulsion, a Natural Breakthrough in Stroke Recovery
TL;DR
Lorati Co., Ltd.'s Nano-Emulsion offers a groundbreaking advantage for stroke recovery, providing a non-invasive, at-home therapy that outperforms conventional treatments.
Lorati Nano-Emulsion works by cleansing the body of inhibitory factors, enabling endogenous stem cells to regenerate damaged brain tissue through a natural, mineral-based process.
This medical breakthrough by Lorati Co., Ltd. promises a brighter future for stroke patients, offering hope for full recovery and improving quality of life worldwide.
Lorati's Nano-Emulsion has achieved the first recorded complete recovery from a severe brainstem stroke, marking a historic milestone in medical science.
Found this article helpful?
Share it with your network and spread the knowledge!
Lorati Co., Ltd., a leader in nano-grade biomedical innovation, has unveiled Lorati Nano-Emulsion, a revolutionary natural therapy designed to support the full recovery of stroke patients. This mineral-based emulsion represents a significant advancement in stroke treatment, providing a non-invasive option that patients can administer at home. The therapy involves daily consumption of 1,600 to 2,000 cc of the emulsion, with recovery periods varying from 12 to 30 months based on the stroke type and the patient's overall health condition.
The science behind Lorati Nano-Emulsion focuses on addressing the root causes of stroke damage. It works by clearing blood clots and foam cells, restoring blood vessel elasticity, and removing inhibitory molecules such as AGEs, ALEs, and excessive heavy metals. This cleansing process activates the body's endogenous stem cells, enabling them to regenerate damaged brain tissue through natural processes of differentiation, dedifferentiation, and proliferation.
Mr. David Lo, CEO of Lorati, emphasizes that the therapy's success lies in its ability to harness the body's own regenerative capabilities, distinguishing it from traditional stem cell transplant methods. A notable case of a patient recovering from a central pontine hemorrhagic stroke, one of the most severe types, after 30 months of treatment, has been documented. This achievement has garnered attention from medical experts worldwide, marking a historic milestone in stroke recovery.
Lorati Nano-Emulsion's potential extends beyond brainstem hemorrhagic strokes, with implications for treating other stroke types. The therapy's development is rooted in Lorati's expertise in nano-grade mineral-based medicine, leveraging the healing properties of montmorillonite, known as 'God's extract of clay.' This innovation underscores Lorati's commitment to creating safe, effective, and natural solutions for complex medical challenges.
For more information on Lorati Nano-Emulsion and its applications, visit https://www.lorati.com.tw.
Curated from 24-7 Press Release
